Eton Pharmaceuticals (ETON)
Develops and commercializes rare-disease therapies through product launches and rights agreements.
$57.20
vs last close+1.88 (+3.41%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$0.34
Revenue estimate
$42.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.02$0.07−$0.10−$0.07$0.05$0.05$0.35Pending
Estimate−$0.02$0.09−$0.01$0.16$0.12$0.10$0.19$0.34
Surprise0.0%−22.2%−900.0%−143.8%−58.3%−50.0%+84.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$11.6M$17.3M$18.9M$22.5M$21.3M$24.3M$37.6MPending
Estimate$14.3M$15.1M$20.5M$20.5M$20.0M$22.3M$27.1M$42.0M
Surprise−18.7%+14.2%−7.6%+9.7%+6.5%+8.8%+38.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.76 | — | — |
| Sep 2028 | $0.69 | — | — |
| Jun 2028 | $0.61 | — | — |
| Mar 2028 | $0.56 | — | — |
| Dec 2027 | $0.52 | — | — |
| Sep 2027 | $0.45 | — | — |
| Jun 2027 | $0.40 | — | — |
| Mar 2027 | $0.38 | — | — |
| Dec 2026 | $0.37 | — | — |
| Nov 2026 | $0.34 | — | — |
| Aug 2026 | $0.19 | $0.35 | +84.4% |
| May 2026 | $0.10 | $0.05 | −50.0% |
| Mar 2026 | $0.12 | $0.05 | −58.3% |
| Nov 2025 | $0.16 | −$0.07 | −143.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.76 | — | — | $73.5M | — | — | — |
| Sep 2028 | $0.69 | — | — | $68.3M | — | — | — |
| Jun 2028 | $0.61 | — | — | $64.7M | — | — | — |
| Mar 2028 | $0.56 | — | — | $60.8M | — | — | — |
| Dec 2027 | $0.52 | — | — | $54.2M | — | — | — |
| Sep 2027 | $0.45 | — | — | $58.7M | — | — | — |
| Jun 2027 | $0.40 | — | — | $54.4M | — | — | — |
| Mar 2027 | $0.38 | — | — | $40.9M | — | — | — |
| Dec 2026 | $0.37 | — | — | $45.9M | — | — | — |
| Nov 5, 2026 | $0.34 | — | — | $42.0M | — | — | — |
| Aug 13, 2026 | $0.19 | $0.35 | +84.4% | $27.1M | $37.6M | +38.7% | +44.3% |
| May 14, 2026 | $0.10 | $0.05 | −50.0% | $22.3M | $24.3M | +8.8% | +1.0% |
| Mar 19, 2026 | $0.12 | $0.05 | −58.3% | $20.0M | $21.3M | +6.5% | +7.5% |
| Nov 6, 2025 | $0.16 | −$0.07 | −143.8% | $20.5M | $22.5M | +9.7% | −11.7% |
| Aug 7, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 16, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 25, 2019 | |||||||
| Dec 20, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 |